Krka DD Novo Mesto operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Krka DD Novo Mesto with three other
pharmaceutical manufacturers in Europe:
sales of 1.15 billion Euro [US$1.30 billion]
of which 84%
(1.07 billion Euro [US$1.20 billion]
of which 95%
was Pharmaceuticals Business), and
Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Reszvenytarsasag
based in Hungary
(389.69 billion Hungarian Forints [US$1.42 billion]
of which 81%
was Pharmaceutical Manufacturing and Sale).
Krka DD Novo Mesto reported sales of 1.17 billion Euro (US$1.32 billion)
December of 2016.
a very small
increase of 0.8%
versus 2015, when the company's sales were 1.16 billion Euro.
Despite this increase, sales are still
below the level achieved in 2014, when Krka DD Novo Mesto
reported sales of 1.19 billion Euro.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Krka DD Novo Mesto had sales
of 1.08 billion Euro.
Sales of Others saw an increase
that was more than double the company's growth rate: sales were up
14.1% in 2016, from
39.87 million Euro to 45.50 million Euro.
Krka DD Novo Mesto also saw significant increases in sales in
Eastern Europe (up 1.5% to 332.29 million Euro)
South East Europe (up 4.5% to 58.26 million Euro)
Not all segments of Krka DD Novo Mesto experienced an increase in sales in 2016:
sales of European Union fell 0.4% to 738.38 million Euro.